E. Pérez

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 386 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting

Marta Durán, E. Pérez, Sergio Abanades et al. · British Journal of Clinical Pharmacology · 2010 · 154 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs

Luisa Ibáñez, E. Pérez, Xavier Vidal et al. · Journal of Hepatology · 2002 · 138 citations

Medicine, Infectious Diseases, Clinical Epidemiology +11

Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza

Jesús Castilla, Pere Godoy, Iván Martínez‐Baz et al. · Clinical Infectious Diseases · 2013 · 124 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +15

Risk of acute liver injury associated with the use of drugs: a multicentre population survey

Mònica Sabaté, Luisa Ibáñez, E. Pérez et al. · Alimentary Pharmacology & Therapeutics · 2007 · 67 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +7